Feeds › Clinical trial updates
Clinical trial updates
Drug and device trials that companies register on ClinicalTrials.gov: newly completed phase 3 studies, changes of status and the dates a study is due to finish.
About this data
- What it is
- ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
- Who files it
- The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
- How current
- We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
- Terms
- ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
- Worth knowing
- A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
- Not to be confused with
- FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.
All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.
Source and freshness · Information, not investment advice (disclaimer).
Studies updated per day, last 30 days
All industry-sponsored studies Sponsor matched to a public company
By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.
Latest clinical trial updates
Showing: ticker ANGO · All recent updates
Studies by the date their record was last updated.
| Updated | Study | SponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private. | PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages. | StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time). | Enrolled | Primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update. | Source |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men… NCT07640776 · Lower Urinary Tract Symptoms (LUTS) in Men With Benign Pros… Irreversible Electroporation | ANGO Angiodynamics, Inc. | Not applicable | Not yet recruiting | 40 | Dec 2027 | Registry ↗ |
| Jun 2, 2026 | Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue NCT04972097 · Prostate Cancer Irreversible Electroporation | ANGO Angiodynamics, Inc. | Not applicable | Completed | 121 | Aug 14, 2024 | Registry ↗ |
| May 18, 2026 | Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Periphera… NCT04229563 · Infrainguinal Peripheral Artery Disease, Peripheral Arteria… AURYON Atherectomy System | ANGO Angiodynamics, Inc. | — | Completed | 102 | Mar 17, 2021 | Registry ↗ |
| May 11, 2026 | Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and… NCT07280247 · Pulmonary Embolism Acute AlphaReturn Blood Management System | ANGO Angiodynamics, Inc. | Not applicable | Recruiting | 39 | Dec 2026 | Registry ↗ |
| Apr 22, 2026 | Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients Wi… NCT07282002 · Infective Endocarditis (IE) AngioVac System | ANGO Angiodynamics, Inc. | Not applicable | Not yet recruiting | 30 | Nov 2026 | Registry ↗ |
| Mar 16, 2026 | Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alo… NCT07472439 · Peripheral Arterial Disease Auryon Atherectomy System, Balloon Angioplasty | ANGO Angiodynamics, Inc. | Not applicable | Not yet recruiting | 50 | May 2029 | Registry ↗ |
| Jan 8, 2026 | Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alo… NCT06777901 · Peripheral Arterial Diseases Auryon Atherectomy System, Balloon Angioplasty | ANGO Angiodynamics, Inc. | Phase 4 | Recruiting | 224 | Feb 2029 | Registry ↗ |
| Oct 10, 2025 | International Study on Treatment of Liver (HCC) Patients With IRE NCT07192731 · Hepatocellular Carcinoma (HCC), Liver Ablation Irreversible Electroporation | ANGO Angiodynamics, Inc. | Not applicable | Not yet recruiting | 50 | Feb 2028 | Registry ↗ |
| Oct 10, 2025 | International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With… NCT07191548 · Colorectal Adenocarcinoma Metastatic in the Liver, Liver Ab… Irreversible Electroporation | ANGO Angiodynamics, Inc. | Not applicable | Not yet recruiting | 50 | Feb 2028 | Registry ↗ |
| Sep 26, 2025 | Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspira… NCT06697314 · Acute Pulmonary Embolism (PE), Pulmonary Embolism AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 Sys… | ANGO Angiodynamics, Inc. | Not applicable | Recruiting | 256 | Jun 2028 | Registry ↗ |
| Feb 12, 2025 | A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer NCT03899649 · Stage III Pancreatic Cancer SOC, NanoKnife System | ANGO Angiodynamics, Inc. | — | Active, not recruiting | 532 | Apr 2025 | Registry ↗ |
| Feb 12, 2025 | A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer NCT03899636 · Stage III Pancreatic Cancer Modified FOLFIRINOX Regimen, NanoKnife System | ANGO Angiodynamics, Inc. | Phase 3 | Active, not recruiting | 528 | Apr 2025 | Registry ↗ |
| Jul 19, 2024 | Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 P… NCT05318092 · Pulmonary Embolism, Acute Pulmonary Embolism AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE | ANGO Angiodynamics, Inc. | Not applicable | Completed | 122 | Jan 4, 2024 | Registry ↗ |
| Feb 1, 2023 | Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients NCT01972867 · Prostate Cancer NanoKnife Procedure | ANGO Angiodynamics, Inc. | Not applicable | Unknown | 6 | Nov 1, 2022 | Registry ↗ |
| May 19, 2020 | SeCure Endovenous Laser Treatment Study NCT02215369 · Chronic Venous Insufficiency VenaCure EVLT 400 µm fiber Procedure Kit | ANGO Angiodynamics, Inc. | Not applicable | Completed | 112 | Mar 2018 | Registry ↗ |
| May 17, 2019 | The PROOF Study: The PICC Related Obstruction Of Flow Study NCT01921114 · Patients Indicated for a PICC for Any Medical Condition BioFlo™ Peripherally Inserted Central Catheter (PICC), Bard… | ANGO Angiodynamics, Inc. | Not applicable | Terminated | 57 | Jul 2014 | Registry ↗ |
| Dec 8, 2017 | Initial Experience With the AngioVac Venous Drainage Cannula NCT02775565 · Heart Disease AngioVac | ANGO Angiodynamics, Inc. | — | Completed | 51 | Sep 2016 | Registry ↗ |
| Nov 8, 2016 | NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pa… NCT01369420 · Pancreatic Adenocarcinoma NanoKnife Low Energy Direct Current (LEDC) System Ablation | ANGO Angiodynamics, Inc. | Phase 2 | Completed | 10 | Dec 2011 | Registry ↗ |
| Nov 8, 2016 | Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) NCT01078415 · Carcinoma, Hepatocellular Ablation with the NanoKnife Low Energy Direct Current (LEDC… | ANGO Angiodynamics, Inc. | Not applicable | Completed | 26 | Jan 2013 | Registry ↗ |
| Nov 8, 2016 | Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE) NCT01064895 · Acute Kidney Injury, Acute Renal Failure Benephit catheter for Targeted Renal Therapy | ANGO Angiodynamics, Inc. | — | Terminated | — | Dec 2011 | Registry ↗ |
20 items, most recent first (up to 50). Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 8:12 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances